索尔皮德姆用于治疗卡塔托尼亚:系统性审查
Matthew Gunther1, Nathan Tran1, Shixie Jiang2
1Stanford University, School of Medicine, Department of Psychiatry and Behavioral Sciences, Stanford, CA.
Journal of the Academy of Consultation-Liaison Psychiatry
|November 10, 2024
概括
索尔皮德姆在治疗白内障方面显示出80%的积极反应率,在二zepines失败时提供了一个有前途的替代方案. 需要进一步的研究,因为依赖于这种猫治疗的案例研究.
科学领域:
- 精神病学是一个精神病学.
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 卡塔托尼是一种与神经递质干扰相关的精神运动综合征,通常涉及GABAergic系统功能障碍.
- 像洛拉泽帕姆这样的二类药物是第一线治疗方法,但高达27%的患者表现出有限的反应.
- 由于其独特的药理动力学和药理动力学特性,zolpidem具有潜在的治疗选择.
研究的目的:
- 系统地审查有关索尔皮德姆在成人白内障管理中的疗效的证据.
- 为了比较索尔皮德姆的临床效用与已建立的治疗方法,如洛拉泽帕姆和电疗法.
主要方法:
- 通过使用PubMed,EMBASE和Web of Science进行了系统性审查.
- 搜索的重点是皮和卡塔托尼,遵循PRISMA指南.
- 确定并分析了29项研究,包括案例研究和系列研究.
主要成果:
- 研究人员审查了35例用于治疗白内障的佐尔皮的病例 (平均年龄为51.5岁,68.6%为女性).
- 积极响应率因药物使用而异:91% (挑战),100% (单疗法),57% (组合治疗),70% (单疗法二线治疗),100% (增强治疗).
- 总体而言,报告的百分之八十 (28/35) 的catatonia病例表现出对皮的积极反应.
结论:
- 佐尔比在白内障病例中显示出80%的阳性反应率,尽管存在潜在的报告偏差.
- 它的有效性可能源于选择性结合GABAA受体α1亚单元.
- 皮是一种潜在的未充分利用的治疗方法,特别是当二类药物无效或ECT访问有限时.
相关概念视频
01:19Management of Insomnia
231
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
231
01:23Sedatives and Hypnotics: Overview
279
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
279
01:19Sedatives and Hypnotics Drugs: Benzodiazepines
194
Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
194
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
146
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
146
01:26Psychosis: Goals of Pharmacotherapy
104
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
104
01:24Mania and Antimanic Drugs: Overview
136
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
136